arbiter
JournalsAccount

Impact of 340B Exposure on Treatment Utilization and Cost for Medicare Patients With Cancer

Danea Horn & Kevin A. Schulman

Health Services Research2026https://doi.org/10.1111/1475-6773.70092article
AJG 3ABDC A
Weight
0.50

Abstract

Findings are consistent with the financial incentives of the 340B program and highlight that the program has a broad impact on patient care and cost. Policymakers should consider ways to support safety net providers that are not tied to outpatient medications.

Open via your library →

Cite this paper

https://doi.org/https://doi.org/10.1111/1475-6773.70092

Or copy a formatted citation

@article{danea2026,
  title        = {{Impact of 340B Exposure on Treatment Utilization and Cost for Medicare Patients With Cancer}},
  author       = {Danea Horn & Kevin A. Schulman},
  journal      = {Health Services Research},
  year         = {2026},
  doi          = {https://doi.org/https://doi.org/10.1111/1475-6773.70092},
}

Paste directly into BibTeX, Zotero, or your reference manager.

Flag this paper

Impact of 340B Exposure on Treatment Utilization and Cost for Medicare Patients With Cancer

Flags are reviewed by the Arbiter methodology team within 5 business days.

Evidence weight

0.50

Balanced mode · F 0.40 / M 0.15 / V 0.05 / R 0.40

F · citation impact0.50 × 0.4 = 0.20
M · momentum0.50 × 0.15 = 0.07
V · venue signal0.50 × 0.05 = 0.03
R · text relevance †0.50 × 0.4 = 0.20

† Text relevance is estimated at 0.50 on the detail page — for your query’s actual relevance score, open this paper from a search result.